Related Experiment Video

Updated: May 28, 2026

Adult and Pediatric Porcine Model of Acute Volume Overload
06:09

Adult and Pediatric Porcine Model of Acute Volume Overload

Published on: January 12, 2024

Pediatrics: a unique and volatile risk

Paul Greve1

  • 1Willis Health Care Practice, USA.

Journal of Healthcare Risk Management : the Journal of the American Society for Healthcare Risk Management
|October 13, 2011
PubMed

Insights

Pediatric patients, especially infants and those with chronic conditions, face unique risks in healthcare settings, leading to severe medical errors and volatile malpractice claims. This review examines pediatric care challenges and proposes risk management strategies.

Area of Science:

  • Pediatric healthcare
  • Medical risk management
  • Patient safety

Background:

  • Children are uniquely vulnerable in healthcare settings, particularly in acute care.
  • Children with chronic conditions present complex treatment challenges and are at higher risk for medical errors.
  • Volatile malpractice claims often involve severely injured pediatric patients, especially those under one year of age.

Purpose of the Study:

  • To provide context on pediatric care, demographics, and healthcare delivery systems.
  • To review unique factors contributing to increased pediatric risk.
  • To discuss low-frequency/high-severity claims and propose risk management solutions.

Main Methods:

  • Review of pediatric care demographics and healthcare delivery.
  • Analysis of unique risk factors in pediatric treatment.
  • Detailed discussion of low-frequency/high-severity claims and general pediatrics physician claims.

Main Results:

  • Identified unique vulnerabilities and risks associated with pediatric patients.
  • Highlighted the challenges in treating children, particularly those with chronic conditions.
  • Examined specific types of high-severity claims involving pediatric patients.

Conclusions:

  • Pediatric care presents distinct and volatile risks, necessitating specialized approaches.
  • Effective risk management strategies are crucial to mitigate medical errors in children.
  • Addressing the unique needs of pediatric patients can reduce malpractice claims and improve outcomes.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...